Bottom line
GDOC vs VGHCX: the short answer
GDOC (Goldman Sachs Future Health Care Equity ETF) and VGHCX (Vanguard Health Care Fund) share a meaningful slice of their top holdings — about 50% by weight.
But VGHCX is far broader, holding 97 positions to 42 for GDOC, so beyond the top names it adds exposure GDOC doesn't have.
VGHCX is cheaper at 0.33% vs 0.75% — a difference of $42 a year per $10,000 invested.
Over one year, VGHCX returned +17.3% vs −1.6% for GDOC (reporting dates differ).
Updated Nov 19, 2026
GDOC vs VGHCX side by side
| GDOC | VGHCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Goldman Sachs | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 0.33% |
| Annual cost per $10k | $75 | $33 |
| 10-yr cost on $10k (prospectus) | $930 | $418 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.6% | +17.3% |
| 5-yr return (annualized) | — | +6.6% |
| 10-yr return (annualized) | — | +7.7% |
| Best quarter | +10.7% | +16.8% |
| Worst quarter | −13.5% | −12.3% |
| Net assets (fund) | $20.1M | $38.2B |
| Number of holdings | 42 | 97 |
| Portfolio turnover | 46% | 47% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GDOC | VGHCX | Difference |
|---|---|---|---|
| 2024 | −1.6% | −1.6% | 0.0% |
| 2023 | +4.9% | +5.4% | −0.5% |
| 2022 | −16.9% | −1.1% | −15.9% |
Source: Fund prospectus bar charts
Holdings overlap
11 of GDOC's top 25 holdings also appear in VGHCX's top 25.
| Holding | GDOC | VGHCX |
|---|---|---|
| Eli Lilly & Company | 13.28% | 8.61% |
| Johnson & Johnson | 8.07% | 4.83% |
| Merck & Company Inc | 5.94% | 5.44% |
| Astrazeneca Plc | 4.84% | 4.59% |
| Intuitive Surgical Inc | 3.90% | 2.52% |
| Boston Scientific Corp | 3.78% | 1.53% |
| Edwards Lifesciences Corp | 2.98% | 2.56% |
| Dexcom Inc | 2.79% | 1.18% |
| Agilent Technologies Inc | 2.77% | 1.49% |
| Cencora Inc | 2.34% | 2.47% |
| Vertex Pharmaceuticals Inc | 1.48% | 2.36% |
Source: SEC Form N-PORT
GDOC top 10
- Eli Lilly & Company — 13.28%
- Johnson & Johnson — 8.07%
- Merck & Company Inc — 5.94%
- Guardant Health Inc — 5.34%
- Astrazeneca Plc — 4.84%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Intuitive Surgical Inc — 3.90%
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
FAQ
What is the difference between GDOC and VGHCX?
Which is cheaper, GDOC or VGHCX?
Should I own both GDOC and VGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.